JAK2 and myeloproliferative disorder: Though an increased understanding of MPN onset has been gathered in the recent years since the identification of the JAK2 (and others) mutations, scarce input has been gathered from the few mouse models and patient studies to gain further insights into the evolution of the disease to MF.